Among adults with outpatient respiratory syncytial virus (RSV) infections across six RSV seasons, roughly one in 20 were ...

Merck said on Tuesday a study showed its injectable version of cancer drug Keytruda was not inferior to the currently ...

Among participants in the landmark ORAL Surveillance study assigned to the JAK inhibitor tofacitinib (Xeljanz) and also using ...

The news outlet is pushing the Commission to release text messages that the E.U.’s top official and Pfizer exchanged as they ...

Donald Trump has delivered a blow to the drug makers he claims hampered his 2020 election bid with the appointment of vaccine ...

Experts view BridgeBio’s acoramidis—which has an FDA action date of Nov. 29—as either similar to or incrementally better than ...

Heidi Chen is a "celebrated and well-respected business leader and general counsel who brings extensive industry experience ...

Pfizer's drug approvals and advertising revenue could be affected by RFK Jr.'s potential appointment. See why PFE stock is a ...

Pfizer is currently assessing the potential divestiture of its hospital drugs unit, a division mainly focused on antibiotics ...

High-yield dividend stocks have been gaining momentum ahead of potential Fed rate cuts. While sticky inflation and possible ...

A Las Vegas woman is not only fighting for her life, but also against a pharmaceutical company after her tumors could be ...

We recently compiled a list of the Jim Cramer Talked About These 11 Stocks Recently. In this article, we are going to take a look at where Pfizer Inc. (NYSE:PFE) stands against the other stocks Jim ...